Hikma, GP Pharm sign license supply agreement Lutrate1 month

Hikma, GP Pharm sign license and supply agreement for Lutrate1 month

7:21 AM, 25th October 2012
Hikma, GP Pharm sign license and supply agreement for Lutrate1 month

LONDON, UK: Hikma Pharmaceuticals signed a license and supply agreement for the registration and marketing of Lutrate1 month, GP Pharm’s leading anti-cancer compound, for the Middle East and North Africa. Lutrate1 month (leuprolide acetate 3.75 mg) is a hormonal androgen deprivation therapy to prevent tumor growth in patients with advanced prostate cancer.

Hikma will have the licensing rights to register, market and distribute Lutrate1 month in 23 countries across Middle East and North Africa. Hikma will also become the partner of choice in the Middle East and North Africa for GP Pharm’s pipeline of oncology products.

“Hikma is committed to improving the treatment of cancer in the region through the development of our oncology product portfolio. We are pleased to be licensing this innovative injectable treatment, which has excellent potential and complements our portfolio and pipeline. It is in line with Hikma’s aim to deliver a reliable supply of high quality pharmaceutical products to Middle East and North Africa that reduce patients’ dependency on a single source for treatment,” said Mazen Darwazah, Chairman and CEO for Middle East and North Africa, Hikma.

© WOC News 



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Fluor bags OG&E’s power maintenance services contract

IRVING, US: Fluor Corporation is awarded a 5-year contract by Oklahoma Gas and Electric (OG&E) to provide maintenance and construction services fo ...

Read more
Sasol opens LAN granulation plant in Secunda, South Africa

MPUMALANGA, SOUTH AFRICA: Sasol Nitro inaugurated its new limestone ammonium nitrate (LAN) granulation plant in Secunda, Mpumalanga, South Africa. The ...

Read more
DSM hikes solar coatings capacity in Netherlands

HEERLEN, THE NETHERLAND: Royal DSM will increase the installed manufacturing capacity for KhepriCoat anti-reflective coating. The additional capacity ...

Read more
Merck to use Epson’s ink technology to manufacture ink for OLED displays

DARMSTADT, GERMANY/TOKYO, JAPAN: Merck and Seiko Epson Corporation announced a cooperation and licensing agreement for inkjet inks used in the manufac ...

Read more
Naoaki Yabuuchi honoured with “Science Award Electrochemistry”

WOLFSBURG/LUDWIGSHAFEN, GERMANY: The first international “Science Award Electrochemistry” from BASF and Volkswagen goes to Dr Naoaki Yabuu ...

Read more
Lonza, OncoMed collaborate for anti-cancer therapeutics

BASEL, SWITZERLAND/REDWOOD CITY, US: Lonza and OncoMed Pharmaceuticals Inc, a clinical-stage biopharmaceutical company dedicated to improving cancer t ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X